Troubleshooting Complications of Intrathecal Baclofen Therapy
نویسندگان
چکیده
منابع مشابه
[Intrathecal baclofen therapy for hereditary spastic paraplegia].
Intrathecal baclofen therapy (ITB) is an established treatment for intractable spasticity. More than 1,100 patients have undergone ITB in Japan, and there are about 50 hereditary spastic paraplegia (HSP) The features of ITB in HSP are 1. small doses of baclofen may often be enough, 2. small changes of doses later the symptoms remarkably, 3. doses can be decreased after long term ITB.
متن کاملComplications of Intrathecal Baclofen Pump: Prevention and Cure
Increasingly, spasticity is managed with surgically implanted Intrathecal Baclofen pumps. Intrathecal Baclofen pump revision surgery unrelated to programmable pump end-of-life is not uncommon, requiring special attention during pre-, intra-, and postoperative management. We aimed to identify and describe complications of Intrathecal Baclofen pump as well as to report avoidance and management of...
متن کاملCerebellar ataxia and intrathecal baclofen therapy: Focus on patients´ experiences
Elucidating patients´ experiences of living with chronic progressive hereditary ataxia and the symptomatic treatment with intrathecal baclofen (ITB) is the objective of the current study. A multicenter qualitative study with four patients included due to the rare combination of hereditary ataxia and ITB therapy was designed to elucidate participants' experiences through semi-structured intervie...
متن کاملBest Practices for Intrathecal Baclofen Therapy: Patient Selection.
INTRODUCTION When spasticity interferes with comfort, function, activities of daily living, mobility, positioning, or caregiver assistance, patients should be considered for intrathecal baclofen (ITB) therapy. METHODS An expert panel consulted on best practices. RESULTS ITB can be considered for problematic spasticity involving muscles/muscle groups during all phases of diseases, including ...
متن کاملLife-threatening constipation induced by intrathecal baclofen therapy.
drugs (4 azathioprine, 2 methotrexate, 1 interferon beta-1b, 8 gabapentin, 2 pregabalin, 2 phenobarbital, 2 paroxetine, 1 citalopram, 1 venlafaxine, 7 furosemide, 4 heparin, 1 risperidone and 1 olanzapine). Fifteen patients did not receive any concomitant medication. ITB was administered with a mean effective daily dose of 251.3 8 11 g (range 90–580 g). Adverse events of ITB were monitored by e...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Physical Medicine and Rehabilitation - International
سال: 2017
ISSN: 2471-0377
DOI: 10.26420/physmedrehabilint.2017.1126